Beranda › Kanker Paru Non-Sel Kecil › Illinois › Waukegan
Uji klinis Kanker Paru Non-Sel Kecil di Waukegan, IL
16 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Waukegan (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi jauhnya
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- City of Hope Chicago, Zion · 6 mi jauhnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mi jauhnya
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mi jauhnya
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi jauhnya
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Menerima pesertaFase 3
- Research Site, Zion · 6 mi jauhnya
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, North Chicago · 3 mi jauhnya
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Menerima pesertaFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi jauhnya
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Menerima pesertaFase 3
- Cancer Treatment Centers of America (CTCA), Zion · 6 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
- dan 1 lainnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
- dan 1 lainnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
- dan 1 lainnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi jauhnya
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Menerima pesertaFase 2
- City of Hope at Chicago, Zion · 6 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Waukegan
- Kanker Paru16 studi
- Kanker Payudara12 studi
- Kolitis Ulseratif7 studi
- Kanker Ginjal (Karsinoma Sel Renal)7 studi
- Kanker Ovarium6 studi
- Kanker Metastatik6 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Kanker Kolorektal6 studi
- Kanker Prostat6 studi
- Melanoma5 studi
- Leukemia Mieloid Akut5 studi
- Penyakit Crohn5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.